Pigeon Circovirus and Young Pigeon Disease

Overview and Taxonomy of Pigeon Circovirus and Young Pigeon Disease Syndrome

Pigeon circovirus (PiCV), a member of the family Circoviridae, genus Circovirus, represents one of the most significant and ubiquitous viral pathogens affecting domestic and feral pigeon populations (Columba livia domestica) worldwide. First described in the scientific literature in the early 1990s, PiCV has since been recognized as a cornerstone pathogen in the complex aetiology of Young Pigeon Disease Syndrome (YPDS), a debilitating and frequently fatal condition that primarily afflicts juvenile birds [6, 12]. The virus was initially identified through histopathological examination of bursal tissue from young racing pigeons exhibiting characteristic lesions, and subsequent molecular characterization has confirmed its presence across all major pigeon-rearing continents, including Europe, Asia, Australia, North America, and Africa [6, 12, 21]. The extreme genetic diversity of PiCV, driven by high rates of recombination and positive selection, poses substantial challenges for diagnostics, vaccine development, and our fundamental understanding of its pathogenic mechanisms [12, 16]. Critically, the relationship between PiCV infection and YPDS is not straightforward; while PiCV was long considered the primary causative agent, rigorous experimental evidence has demonstrated that other pathogens, notably pigeon Rotavirus A genotype G18P[15], can independently induce YPDS-like disease, indicating a far more complex, multifactorial pathogenesis than originally proposed [4, 6, 14]. This re-evaluation necessitates a nuanced understanding of PiCV’s role as an immunosuppressive predisposing factor rather than a sole etiological agent, a paradigm shift that frames the current state of research.

Taxonomy and Molecular Characteristics of Pigeon Circovirus

PiCV is a small, non-enveloped virus with a circular, single-stranded DNA (ssDNA) genome, typically ranging from 2036 to 2039 nucleotides in length [5, 12]. The genomic organization is characteristic of circoviruses, featuring two major open reading frames (ORFs): ORF V1, which encodes the replication-associated protein (Rep), and ORF C1, which encodes the capsid protein (Cap) [6, 29]. The Rep protein is essential for rolling-circle replication of the viral genome, while the Cap protein is the sole structural component of the virion, responsible for both capsid assembly and elicitation of host humoral immune responses [10, 11]. The Cap protein is highly immunogenic and contains neutralizing antibody epitopes, making it the primary target for subunit vaccine development and serological diagnostics [8, 9, 11].

Phylogenetic analysis has revealed remarkable genetic heterogeneity among PiCV isolates, with at least 13 distinct genotypes (designated A through M) identified through whole-genome sequencing [3, 16]. Studies utilizing comprehensive genome recovery under One Loft Race (OLR) rearing conditions have documented 25 recombination events within a single experimental cohort, demonstrating that recombination is a major evolutionary driver facilitating the emergence of novel viral variants [16]. These recombination events, often occurring within the Rep gene, can generate chimeric viruses with altered pathogenic potential or tropism. The virus also exhibits a high degree of point mutation accumulation, with positive selection acting on specific genomic regions, particularly those encoding the Cap protein, likely as an immune evasion strategy [12, 29]. This genetic plasticity complicates diagnostic PCR design, as primer binding sites can be highly variable, necessitating the use of broadly reactive primers targeting conserved regions of the Rep gene or the development of pan-genotypic detection methods such as the recently developed indirect competitive ELISA (icELISA) targeting a conserved conformational epitope on the Cap protein [5, 20].

Historical Context and the Elusive Aetiology of Young Pigeon Disease Syndrome

YPDS, also referred to as classical young pigeon disease, was first described in the late 1980s as an acute, seasonally recurring disorder affecting juvenile domestic pigeons, particularly during the summer racing season [4, 22]. The syndrome is characterized by a constellation of clinical signs including lethargy, anorexia, crop stasis, regurgitation, watery diarrhea, weight loss, and variable mortality rates that can exceed 50% in severe outbreaks [4, 6, 14]. For decades, PiCV was considered the central etiological agent due to its ubiquitous detection in diseased birds and its well-documented immunosuppressive properties [8, 10, 11]. The virus was frequently identified in association with YPDS-affected flocks, and its ability to cause atrophy of lymphoid organs (bursa of Fabricius, thymus, spleen) and lymphocyte apoptosis led to the prevailing hypothesis that PiCV-induced immunosuppression rendered young pigeons vulnerable to secondary infections by adenoviruses, Escherichia coli, Chlamydia psittaci, or other opportunistic pathogens, culminating in the full YPDS clinical picture [15, 17, 23].

However, a critical turning point in understanding YPDS aetiology came with the landmark experimental fulfillment of Henle-Koch postulates for pigeon Rotavirus A (RVA) genotype G18P[15] in 2020 [14]. Peroral inoculation of juvenile homing pigeons with cell culture isolates of RVA G18P[15] reproducibly induced an acute, self-limiting disease indistinguishable from classical YPDS, including regurgitation, diarrhea, congested crops, anorexia, and weight loss [14]. Subsequent studies confirmed that RVA-associated disease outbreaks occur globally, with the virus detected in Australia, Europe, Asia, and North America, often in association with show or racing events [19, 22, 24]. This experimental proof established that RVA alone is sufficient to cause YPDS, directly challenging the primacy of PiCV as the sole causative agent. Consequently, the role of PiCV has been re-conceptualized. Rather than being the primary trigger, PiCV is now understood to be a profound immunosuppressive co-factor that can exacerbate the severity of disease caused by other pathogens, including RVA, adenoviruses, and herpesviruses [1, 2, 15, 17].

Pathogenesis and Immunosuppression: The Biologic Mechanism of PiCV

The pathogenic hallmarks of PiCV infection are its direct cytopathicity for lymphoid tissues and its consequent induction of immunosuppression. The virus demonstrates a marked tropism for the bursa of Fabricius, the primary lymphoid organ responsible for B lymphocyte maturation in birds, as well as the spleen, thymus, and gut-associated lymphoid tissue [12, 21]. Histopathological examination of infected bursae reveals characteristic botryoid (grape-like) intracytoplasmic inclusion bodies within bursal macrophages and histiocytes, accompanied by lymphocytolysis, follicular depletion, and severe atrophy of lymphoid follicles [15, 17]. These lesions are pathognomonic for circovirus infection in pigeons and result in profound B cell apoptosis, evidenced by up to 40% higher proportions of apoptotic splenic IgM+ B cells in infected birds compared to controls [13].

The molecular mechanisms underlying PiCV-mediated immune evasion are beginning to be elucidated. The capsid protein of PiCV, like that of other circoviruses, has been shown to modulate type I interferon (IFN) signaling, a critical arm of the innate antiviral response [29]. While the porcine circovirus type 2 (PCV2) Cap protein potently inhibits IFN-β induction, studies indicate that the effects of PiCV Cap on interferon signaling are divergent, suggesting species-specific viral strategies for subverting host immunity [29]. This interferon modulation likely facilitates viral persistence and creates an environment permissive for secondary infections. The immunosuppressive state induced by PiCV is perhaps best illustrated by frequent co-infections. Studies have consistently documented high rates of concurrent infection with pigeon aviadenovirus A, columbid alphaherpesvirus 1 (CoHV-1), Chlamydia psittaci, and pigeon RVA [1, 2, 15, 17, 19]. For instance, in an outbreak of CoHV-1 in an Australian racing pigeon flock, birds co-infected with PiCV exhibited significantly higher viral copy numbers for both viruses and more severe clinical lesions compared to subclinically infected birds [15]. Similarly, a lethal outbreak of chlamydiosis in a Taiwanese zoo was attributed to concurrent PiCV infection, with the authors concluding that PiCV-induced immunosuppression was the critical factor enabling the devastating severity of the bacterial disease [17].

Defining PiCV Subclinical Infection and Systemic Disease

Given the recognition that PiCV infection can manifest along a clinical spectrum, a formalized classification system has been proposed to standardize diagnosis and facilitate research [6]. This framework distinguishes between PiCV subclinical infection (PiCV-SI) and PiCV systemic disease (PiCV-SD). PiCV-SI is defined by the presence of detectable PiCV DNA in clinical samples (e.g., cloacal swabs, blood, feathers) in the absence of overt clinical signs attributable to the virus [6]. This state is exceptionally common, with prevalence rates often exceeding 80% in surveyed populations [3, 16]. Young pigeons in OLR facilities, where birds from multiple lofts are commingled, are particularly susceptible to acquiring PiCV-SI, with peak viremia typically occurring around 14 days post-exposure, followed by a gradual decline as the developing adaptive immune response gains control [13, 16].

In contrast, PiCV-SD is characterized by the presence of clinical signs consistent with circovirus infection, such as lethargy, poor growth, feather abnormalities, or diarrhoea, accompanied by laboratory confirmation of PiCV infection and the histopathological detection of characteristic bursal lesions or inclusion bodies [6, 15]. However, it is crucial to note that PiCV-SD in isolation appears to be relatively rare; in most clinical presentations, the observed syndrome is a consequence of secondary or concurrent infection, making the diagnosis of "PiCV-induced YPDS" a diagnosis of exclusion and context [4, 6]. The development of sensitive, pan-genotypic serological tools, such as the icELISA, offers the potential to differentiate between active infection and past exposure, providing a more complete epidemiological picture for both subclinical carriers and clinically affected flocks [5]. This diagnostic capacity is essential for implementing targeted biosecurity interventions, particularly in high-density racing and breeding environments where PiCV persists endemically.

Genetic Diversity and Evolutionary Dynamics in High-Density Rearing Systems

The One Loft Race system, where young pigeons from diverse geographic origins are housed and trained together before competition, represents a potent driver of PiCV evolution and transmission [13, 16]. Studies tracking PiCV viremia and shedding in OLR conditions have documented a dynamic interplay between viral replication and host immunity. The highest levels of viral DNA in blood and cloacal swabs occur within the first two to three weeks of co-mingling, corresponding precisely with the period when the greatest number of recombination events are detected [16]. This observation strongly suggests that co-infection of a single host with multiple PiCV genotypes is a common occurrence in such high-contact environments, providing the substrate for homologous recombination during viral replication.

The resulting chimeric genomes can possess novel combinations of genetic properties, potentially altering tissue tropism, immunogenicity, or virulence. The emergence of these recombinants is then modulated by host immune pressure, with increases in IFN-γ and MX1 gene expression, as well as anti-PiCV antibody production, correlating with declining viremia [16, 18]. This continual cycle of co-infection, recombination, and immune selection contributes to the extraordinary diversity of PiCV genotypes circulating globally and poses a formidable challenge for vaccine design. A vaccine based on the Cap protein of a single genotype, even if immunogenic, may offer only partial protection against infection by distantly related field strains [10, 12, 18]. The OLR system, therefore, functions not only as an epidemiological amplifier for PiCV but as a real-time evolutionary laboratory, highlighting the need for more fundamental research into the correlates of protective immunity and the development of broadly protective vaccine strategies.

The Syndemic Nature of YPDS: Integrating Multiple Pathogens

Ultimately, the clinical entity known as YPDS must be understood as a syndemic, a convergence of multiple interacting pathogens and environmental stressors that synergistically produce disease [6, 28]. PiCV likely establishes the foundation by inducing a state of immunological vulnerability in juvenile birds during a critical developmental window when maternal antibody wanes and primary immune responses are still maturing [12, 18, 27]. Upon this immunosuppressed background, a triggering agent, most commonly pigeon RVA G18P[15], but also pigeon aviadenovirus A, CoHV-1, C. psittaci, or pathogenic E. coli, can initiate the acute clinical syndrome [1, 15, 19, 26]. The specific triggering agent may vary by geographic region, season, and the background microbial flora of the loft, explaining the clinical heterogeneity of YPDS outbreaks. Co-infections are not merely additive; they are synergistic. PiCV infection enhances the replication and pathogenicity of concurrent viral or bacterial infections, leading to severe inflammatory lesions, multi-organ failure, and sudden death [15, 17]. This syndemic paradigm demands a holistic diagnostic approach. A multiplex PCR assay capable of simultaneously detecting PiCV, adenoviruses, RVA, and other key pathogens [7], combined with histopathological examination, is essential for accurate diagnosis and the formulation of effective control strategies tailored to the specific co-infection profile of each affected loft. Furthermore, understanding PiCV's taxonomic relationship to other avian circoviruses, such as beak and feather disease virus (BFDV) in psittacines, underscores the capacity for cross-species transmission and the potential role of pigeons as reservoirs for emerging circovirus infections in other avian taxa [3, 31]. The global distribution of PiCV, its profound impact on pigeon health and welfare, and its interactions with important zoonotic agents such as C. psittaci position it as a pathogen of significant veterinary and public health concern, warranting continued surveillance and research investment [23, 25, 30].

Molecular Pathogenesis and Immunosuppression in PiCV Infection

Pigeon circovirus (PiCV) represents one of the most significant infectious agents affecting global pigeon health, with its pathogenic mechanisms intricately linked to the induction of profound immunosuppression that predisposes infected birds to a wide array of secondary infections [6, 12]. The molecular pathogenesis of PiCV is fundamentally rooted in its tropism for lymphoid tissues, particularly the bursa of Fabricius, spleen, and peripheral blood lymphocytes, where it orchestrates a cascade of cellular destruction and immune dysregulation that underpins the clinical syndrome known as Young Pigeon Disease Syndrome (YPDS) [12, 15]. Understanding these molecular mechanisms is critical for developing effective control strategies, as PiCV infection creates a permissive immunological environment that allows otherwise innocuous pathogens to cause severe, often fatal, disease.

Molecular Mechanisms of Lymphoid Depletion and Apoptosis

The hallmark of PiCV pathogenesis is the progressive atrophy of lymphoid organs, most notably the bursa of Fabricius, which serves as the primary site of B lymphocyte maturation and diversification in avian species [12, 15]. Histopathological examinations of PiCV-infected pigeons consistently reveal characteristic botryoid intracytoplasmic inclusion bodies within bursal histiocytes and macrophages, accompanied by extensive lymphocyte depletion and follicular atrophy [15, 17]. These inclusions represent massive accumulations of viral capsid proteins and viral particles, reflecting the high viral replication capacity within these tissues. The molecular drivers of this lymphoid destruction involve the induction of apoptosis, particularly among B lymphocytes. Studies employing flow cytometry have demonstrated that PiCV infection leads to a marked increase in apoptotic splenic IgM+ B cells, with experimentally infected birds showing approximately 40% higher levels of apoptotic B lymphocytes in the spleen compared to uninfected controls [13]. This B cell apoptosis is a direct consequence of viral replication within these cells, as PiCV DNA is readily detectable in bursal and splenic tissues at high copy numbers [15, 21].

The molecular basis for PiCV-induced apoptosis is not fully elucidated, but evidence from related circoviruses, particularly porcine circovirus type 2 (PCV2), suggests that the capsid protein (Cap) may play a direct role in modulating host cell survival pathways. Recent comparative studies have demonstrated that Circoviridae capsid proteins, including those of PiCV, exhibit divergent effects on type I interferon signaling, with some capsid proteins capable of inhibiting interferon-β induction [29]. This inhibition of innate antiviral responses may create a cellular environment that favors viral replication while simultaneously triggering apoptotic pathways as a consequence of unresolved cellular stress. The replication-associated protein (Rep), encoded by the rep gene, is also implicated in pathogenesis through its interaction with host cell DNA replication machinery, potentially inducing cell cycle arrest and subsequent apoptosis in infected lymphocytes [12]. The high genetic diversity of PiCV, driven by frequent point mutations, recombination events, and positive selection pressures, may contribute to variable pathogenic potential among different genotypes, with some strains exhibiting enhanced capacity for lymphoid depletion [12, 16].

Immunosuppressive Cascade and Susceptibility to Secondary Infections

The immunosuppression induced by PiCV infection creates a permissive immunological state that dramatically increases susceptibility to a wide range of secondary viral, bacterial, and parasitic pathogens. This phenomenon is the cornerstone of YPDS pathogenesis, as PiCV-infected pigeons frequently succumb to coinfections rather than to PiCV itself [1, 2, 15]. The molecular basis for this immunosuppression involves multiple interconnected mechanisms, including direct depletion of B lymphocytes, impairment of T cell responses, and dysregulation of cytokine networks.

B lymphocyte depletion is particularly profound, as PiCV exhibits a strong tropism for bursal and peripheral B cells [13, 15]. The resulting reduction in antibody-producing capacity compromises humoral immunity, leaving pigeons vulnerable to encapsulated bacteria and viruses that require opsonizing antibodies for clearance. This is clinically manifested by the high prevalence of secondary infections with organisms such as Escherichia coli (avian pathogenic E. coli, APEC), Chlamydia psittaci, and various adenoviruses in PiCV-positive birds [1, 2, 23, 26]. Epidemiological studies have demonstrated a striking correlation between PiCV infection and C. psittaci carriage, with coinfected pigeons being two to three times more likely to harbor C. psittaci than PiCV-negative birds [23]. This association is particularly concerning from a public health perspective, as C. psittaci is a zoonotic pathogen capable of causing severe respiratory disease in humans, and the World Health Organization (WHO) recognizes psittacosis as an important occupational zoonosis. The immunosuppressive effects of PiCV likely facilitate C. psittaci shedding and transmission, amplifying zoonotic risk.

T cell responses are also compromised during PiCV infection, although the mechanisms are more nuanced. Studies examining cytokine expression profiles have revealed that PiCV infection modulates interferon-gamma (IFN-γ) and CD8 T cell receptor gene expression [18]. In pigeons naturally infected with PiCV, baseline expression of IFN-γ and CD8 genes is significantly higher than in uninfected birds, suggesting a chronic state of immune activation that may ultimately lead to T cell exhaustion [18]. This chronic activation is accompanied by impaired proliferative responses, as evidenced by the observation that PiCV-infected pigeons show a blunted cellular immune response to vaccination with recombinant capsid protein compared to uninfected birds [18]. The virus appears to hijack the host immune response, creating a state of immune dysregulation where persistent activation leads to functional exhaustion of critical effector cells.

Role of Coinfections in Exacerbating Disease

The immunosuppressive state induced by PiCV creates a permissive environment for a wide array of coinfecting pathogens, and the resulting synergistic interactions are responsible for the severe clinical manifestations characteristic of YPDS. Coinfections with pigeon aviadenovirus A (PiAdV-A) are particularly well-documented and devastating, with natural outbreaks in Turkish pigeon flocks demonstrating that coinfected birds exhibit severe clinical signs including crop vomiting, watery diarrhea, anorexia, and sudden death [1, 2]. Histopathological examination of these cases reveals degenerated hepatocytes with basophilic intranuclear viral inclusions, indicative of active adenoviral replication that is likely potentiated by PiCV-induced immunosuppression [1, 2]. The molecular mechanisms underlying this synergy may involve PiCV-mediated suppression of interferon responses that would normally control adenoviral replication, as type I interferons are critical for limiting adenovirus spread [29].

Similarly, coinfection with columbid alphaherpesvirus 1 (CoHV1) in PiCV-positive pigeons results in exacerbated lesion development and higher viral loads compared to CoHV1 infection alone [15]. In a natural outbreak among Australian racing pigeons, coinfected birds exhibited suppurative stomatitis, pharyngitis, cloacitis, meningitis, and tympanitis, with significantly higher viral copy numbers for both viruses in clinically affected pigeons compared to subclinically infected birds [15]. The presence of eosinophilic intranuclear inclusion bodies consistent with herpesviral infection, alongside circoviral botryoid intracytoplasmic inclusions, demonstrates the permissive environment created by PiCV for herpesvirus reactivation and dissemination [15]. This is particularly relevant given that CoHV1 can establish latency, and PiCV-induced immunosuppression likely triggers viral reactivation, leading to systemic disease.

The interaction between PiCV and C. psittaci is another clinically significant coinfection, with lethal outbreaks documented in zoo settings where concurrent infection led to mortality rates exceeding 50% in affected aviaries [17]. Histopathological examination of these cases revealed variable numbers of intracytoplasmic basophilic microorganisms in macrophages, hepatocytes, and renal epithelium, alongside circoviral inclusion bodies in bursal histiocytes [17]. The immunosuppressive effects of PiCV likely impair the host's ability to contain C. psittaci replication, allowing the bacterium to disseminate systemically and cause fatal disease. This interaction has implications for both animal and human health, as pigeons serve as reservoirs for C. psittaci, and PiCV-mediated enhancement of bacterial shedding could increase zoonotic transmission risk. The World Organisation for Animal Health (WOAH) recognizes chlamydiosis as a notifiable disease, and understanding the role of PiCV in its epidemiology is crucial for risk assessment.

Impact on Vaccine Responses and Immune Memory

The immunosuppressive effects of PiCV have profound implications for vaccine efficacy in pigeon populations. Studies evaluating the immune response to PiCV recombinant capsid protein (rCP) vaccination have demonstrated that PiCV infection status significantly influences the magnitude and quality of the vaccine-induced immune response [18]. In pigeons naturally infected with PiCV, vaccination with rCP elicits a different immune profile compared to uninfected birds, with infected pigeons showing higher baseline expression of CD8 and IFN-γ genes that masks the potential cellular immune response to vaccination [18]. Furthermore, PiCV infection suppresses humoral immunity, as evidenced by delayed seroconversion and lower anti-PiCV rCP IgY antibody levels in infected birds compared to uninfected controls [18]. This suppression of vaccine-induced immunity has practical implications for flock health management, as PiCV-infected pigeons may not mount protective responses to routine vaccinations against pathogens such as pigeon paramyxovirus type 1 (PPMV-1) or avian poxvirus.

The molecular basis for this impaired vaccine response likely involves the depletion of B lymphocyte precursors in the bursa of Fabricius, which compromises the ability to generate antibody-secreting cells [13, 15]. Additionally, the chronic immune activation state induced by PiCV may lead to regulatory T cell expansion or immune checkpoint upregulation, further dampening vaccine responses [18]. These findings underscore the importance of controlling PiCV infection before implementing vaccination programs in pigeon flocks, as the immunosuppressive effects of the virus may render routine vaccinations ineffective.

Genetic Diversity and Pathogenic Potential

The molecular pathogenesis of PiCV is further complicated by the remarkable genetic diversity of the virus, which is driven by high rates of recombination and positive selection [12, 16]. Studies employing whole-genome sequencing of PiCV from pigeons housed under One Loft Race (OLR) conditions have identified 13 distinct genotypes and 25 recombination events within a single six-week experimental period [16]. This genetic plasticity allows PiCV to rapidly evolve, potentially generating variants with altered pathogenic potential or enhanced immunosuppressive capacity. Recombination events were most frequent during the first three weeks of cohousing, coinciding with peak viremia and viral shedding, suggesting that high viral replication rates facilitate genetic exchange between coinfecting strains [16]. The emergence of recombinant viruses may contribute to the variable clinical outcomes observed in PiCV infections, ranging from subclinical infection to severe immunosuppression and YPDS.

The capsid protein, which is the primary target of the host antibody response, exhibits particularly high genetic variability, with amino acid substitutions concentrated in surface-exposed loops that may represent antibody epitopes [5, 12]. This antigenic diversity poses challenges for serological diagnosis and vaccine development, as antibodies generated against one genotype may not neutralize heterologous strains. However, recent advances in serological detection, including the development of a pan-genotypic indirect competitive ELISA (icELISA) using a monoclonal antibody targeting a conserved conformational epitope on the Cap protein, offer promise for comprehensive epidemiological surveillance [5]. This assay demonstrates that despite genetic diversity, there are conserved structural elements within the Cap protein that can be targeted for diagnostic purposes, potentially overcoming the limitations of genotype-specific PCR assays [5].

Conclusion of Pathogenic Mechanisms

The molecular pathogenesis of PiCV infection represents a complex interplay between viral replication, host immune modulation, and secondary pathogen interactions. The virus's tropism for lymphoid tissues, particularly B lymphocytes, leads to profound immunosuppression through direct cytopathic effects and apoptosis induction. This immunosuppressive state creates a permissive environment for a wide range of secondary infections, including adenoviruses, herpesviruses, C. psittaci, and E. coli, which are responsible for the severe clinical manifestations of YPDS. The high genetic diversity of PiCV, driven by recombination and positive selection, allows the virus to evade host immune responses and potentially generate variants with enhanced pathogenic potential. Understanding these molecular mechanisms is essential for developing effective control strategies, including vaccines that can overcome the immunosuppressive effects of PiCV and diagnostic tools that can detect infection across diverse genotypes. The public health implications of PiCV-induced immunosuppression, particularly in relation to zoonotic pathogens such as C. psittaci, underscore the importance of continued research into this economically and medically significant pathogen.

Epidemiology and Transmission Dynamics of PiCV in Pigeon Populations

Pigeon circovirus (PiCV) represents one of the most pervasive and economically significant viral pathogens affecting domestic pigeon populations worldwide, with its epidemiological footprint extending across racing, fancy, and meat production sectors. Since its initial description in the early 1990s, PiCV has been documented on nearly every continent, establishing itself as the most frequently diagnosed virus in pigeons and a central etiological agent implicated in the complex, multifactorial Young Pigeon Disease Syndrome (YPDS) [6, 12]. Understanding the nuanced epidemiology and transmission dynamics of PiCV is not merely an academic exercise; it is a prerequisite for designing effective biosecurity interventions, surveillance programs, and ultimately, control strategies for a pathogen that thrives in the unique ecological and management niches created by human pigeon husbandry.

Global Prevalence and Geographic Distribution

The global distribution of PiCV is remarkable, with molecular evidence of infection reported across Europe, Asia, the Middle East, Australia, and North America. Prevalence rates, however, vary dramatically depending on the population sampled, the diagnostic methodology employed, and the clinical status of the birds. Studies employing highly sensitive polymerase chain reaction (PCR) techniques consistently reveal infection rates that are alarmingly high, particularly in juvenile birds and in populations subjected to the stressors of racing or exhibition.

In a comprehensive survey conducted in Turkey, PiCV genetic material was the most frequently detected viral agent among young pigeons sampled from 16 private flocks between 2018 and 2021, identified in 25% of the flocks tested [32]. This finding is consistent with the initial detection of PiCV in Turkey, where co-infection with pigeon aviadenovirus A was associated with severe YPDS outbreaks in a breeding flock in Central Anatolia [1, 2]. The Iranian experience provides an even more striking illustration of PiCV endemicity. In a study of 100 pigeons from 20 lofts in Ahvaz, PiCV was detected in an astonishing 86% of all samples, with the virus identified in both clinically diseased birds exhibiting lethargy, crop stasis, vomiting, and diarrhea, as well as in apparently healthy pigeons [3]. This high background prevalence underscores a critical epidemiological feature: PiCV circulates extensively within populations, often in a subclinical state, creating a persistent reservoir for transmission.

In Iraq, a study of racing pigeons in Mosul reported high infectivity rates, particularly in ill yearling pigeons (66.7%) compared to healthy adults, and notably detected PiCV DNA in 60.71% of bursa of Fabricius samples from dead-in-shell pigeon embryos, providing compelling evidence for vertical transmission as a significant epidemiological pathway [21]. In India, a multiplex PCR-based investigation of YPDS-suspect pigeons detected PiCV DNA in 5.3% of clinical samples, a figure that likely underestimates true prevalence due to the targeted sampling of acutely ill birds and the potential for viral loads to fluctuate during the course of infection [7]. Australian studies have similarly documented high carriage rates; in a natural outbreak of co-infection with columbid alphaherpesvirus 1 (CoHV1), PiCV was detected in oro-cloacal swabs from 44 of 46 additional birds of variable clinical status, with 23 birds harboring PiCV alone and 21 exhibiting co-infection [15]. These data collectively paint a picture of a globally ubiquitous pathogen, with prevalence rates often exceeding 50% in surveyed populations, a level of endemicity that poses profound challenges for disease control.

Age-Related Susceptibility and the Role of the One Loft Race (OLR) System

A defining epidemiological characteristic of PiCV is its pronounced age-related susceptibility, with young pigeons, particularly those between weaning and the first racing season, exhibiting the highest rates of infection and clinical disease. This pattern is intimately linked to the waning of maternal antibodies and the immunological naivety of juvenile birds, which are exposed to the virus at a time when their bursa of Fabricius, the primary target organ for PiCV replication, is undergoing active development and is highly permissive to infection [12, 13]. The clinical manifestation of YPDS, with its peak incidence in pigeons aged 4–12 weeks, is a direct consequence of this age-dependent vulnerability.

The modern practice of the One Loft Race (OLR) system has emerged as a critical amplifier of PiCV transmission dynamics. In OLR, pigeons from numerous geographically disparate lofts are brought together and housed in a single facility under uniform conditions to eliminate variables in training and husbandry. While designed to ensure competitive fairness, this system creates an ideal epidemiological crucible for pathogen exchange. A landmark study by Stenzel et al. (2024) explicitly investigated the consequences of this system by housing 15 young racing pigeons from five different breeding facilities together for six weeks. The results were stark: 388 complete PiCV genomes were recovered from these birds, and 13 distinct genotypes were distinguished. Crucially, 25 recombination events were detected, with recombinants emerging during the first three weeks of the experiment, a period that coincided precisely with the peak of viremia and viral shedding [16]. This demonstrates that OLR conditions not only facilitate the horizontal transmission of existing strains but actively promote the generation of novel genetic variants through recombination, a process that has profound implications for viral evolution, immune evasion, and the potential emergence of more virulent pathotypes.

Further experimental work mimicking OLR conditions revealed that the viremia peak in co-housed, naturally infected birds occurred on day 14 of the experiment, followed by a subsequent decline as the birds’ adaptive immunity developed [13]. This kinetic pattern highlights the intense, early-phase transmission that occurs when immunologically diverse populations are mixed. The percentage of apoptotic splenic IgM+ B cells was approximately 40% higher in the experimental group than in uninfected controls, underscoring the direct immunosuppressive consequence of PiCV replication even in subclinically infected birds [13]. The OLR system, therefore, functions as a super-spreader environment, where the combination of high population density, stress from transport and novel housing, and the mixing of birds with divergent infection histories creates a perfect storm for PiCV amplification and diversification.

Transmission Routes: Horizontal, Vertical, and Environmental Persistence

The transmission of PiCV is facilitated by multiple, overlapping routes, contributing to its remarkable success as a pathogen. Horizontal transmission via the fecal-oral route is considered the primary mechanism of spread. Infected pigeons shed high quantities of virus in their feces and cloacal secretions, contaminating feed, water, loft surfaces, and dust. The detection of PiCV DNA in environmental samples from high-risk settings, such as international ports of entry, confirms that the virus can persist in the environment and be transported across borders, posing a biosecurity risk [30]. The virus’s small, non-enveloped icosahedral structure, characteristic of the Circoviridae family, confers significant environmental stability, allowing it to remain infectious for extended periods in loft litter and on fomites.

Vertical transmission represents a second, highly consequential epidemiological pathway. The detection of PiCV DNA in the bursa of Fabricius of dead-in-shell pigeon embryos provides definitive evidence that the virus can be transmitted from parent to offspring via the egg [21]. This route is particularly insidious because it allows the virus to persist across generations, establishing infection in squabs before they are even exposed to the external loft environment. Infected squabs may then serve as a source of infection for their hatch-mates and other young birds in the loft, effectively seeding the next cycle of transmission. The high prevalence of PiCV in breeding flocks, as documented in Turkey [1, 2], is likely sustained in part by this vertical transmission mechanism, which circumvents many standard biosecurity measures.

Aerosol transmission, while less well-characterized than fecal-oral or vertical routes, is also plausible given the high viral loads detected in oropharyngeal swabs and the respiratory signs sometimes associated with PiCV infection, particularly in co-infections with agents like CoHV1 [15]. The close confinement of pigeons in lofts, transport baskets, and show halls creates conditions conducive to droplet and dust-borne transmission. The role of fomites, including contaminated feed bags, waterers, and the hands and clothing of fanciers, should not be underestimated. The movement of birds between lofts for breeding, racing, or exhibition is a well-documented risk factor for introducing new PiCV strains into naive populations, as evidenced by outbreaks following fancy pigeon shows [19].

Co-Infection Dynamics and the Amplification of Transmission

PiCV is rarely an exclusive infection; its epidemiological significance is profoundly amplified by its capacity to interact with a wide array of other pathogens. The immunosuppression induced by PiCV, characterized by lymphocyte apoptosis and atrophy of the bursa of Fabricius and spleen, creates a permissive environment for secondary and opportunistic infections, which in turn can alter transmission dynamics. The virus has been identified in co-infections with pigeon aviadenovirus A [1, 2], columbid alphaherpesvirus 1 [15], Chlamydia psittaci [17, 23], rotavirus A [19], and various bacterial pathogens.

The relationship between PiCV and Chlamydia psittaci is particularly instructive from an epidemiological perspective. A study in Poland found that pigeons co-infected with PiCV were two to three times more likely to be infected with C. psittaci than pigeons infected with C. psittaci alone, a trend observed predominantly in sick birds [23]. This suggests that PiCV-induced immunosuppression not only increases susceptibility to chlamydial infection but may also prolong shedding of C. psittaci, thereby enhancing its transmission within the loft and potentially to humans, given the zoonotic potential of this bacterium. A lethal outbreak of chlamydiosis in a zoo, where concurrent PiCV infection was diagnosed in a high proportion of birds, further supports the hypothesis that PiCV augments the lethality and transmissibility of co-infecting agents [17].

Similarly, the co-occurrence of PiCV with rotavirus A (RVA) genotype G18P[15] is a frequent finding in YPDS outbreaks. In a case series of disease outbreaks following fancy pigeon shows in Germany, PiCV was detected in 15 of 18 pigeons diagnosed with RVA infection [19]. While RVA has been experimentally proven to fulfill Henle-Koch’s postulates as a primary cause of YPDS [14], the high prevalence of PiCV in these cases suggests that prior or concurrent PiCV infection may exacerbate clinical disease and prolong viral shedding, thereby increasing the force of infection for RVA within the population. The detection of PiCV in archived samples from Taiwan dating back to 2018, alongside the earliest known RVA isolate from the region, hints at a long-standing and potentially synergistic co-circulation of these viruses [22].

Genetic Diversity, Recombination, and Implications for Transmission

The epidemiological landscape of PiCV is further complicated by its extraordinary genetic diversity, which is driven by high rates of mutation, recombination, and positive selection [12]. The PiCV genome, a circular single-stranded DNA molecule of approximately 2.0 kb, encodes two major open reading frames: the replication-associated protein (Rep) and the capsid protein (Cap). The Cap gene, in particular, is a hotspot for genetic variation, as it is under selective pressure from the host immune system. This diversity has led to the classification of PiCV into multiple genotypes (e.g., A through H), which can co-circulate within a single loft or even within a single bird [3, 16].

Recombination is a major driver of PiCV evolution and has direct implications for transmission dynamics. The study of pigeons in an OLR setting demonstrated that recombination events were frequent and occurred rapidly after the mixing of birds from different sources [16]. The emergence of recombinant viruses during the peak of viremia suggests that co-infection of a single cell with two distinct PiCV strains is a common event, allowing for the generation of chimeric genomes. These novel recombinants may possess altered antigenic profiles, potentially allowing them to evade pre-existing immunity in the population and establish new transmission chains. The high genetic diversity of PiCV also poses a significant challenge for molecular diagnostics; PCR assays must be carefully designed to target conserved regions of the genome, such as the Rep gene, to avoid false-negative results due to primer-template mismatches [20]. The development of pan-genotypic serological assays, such as the indirect competitive ELISA targeting a conserved conformational epitope on the Cap protein, represents a critical advance for epidemiological surveillance, as it can detect antibodies against diverse PiCV strains circulating in the field [5].

The Role of Subclinical Carriers and Biosecurity Implications

A cornerstone of PiCV epidemiology is the existence of a large, clinically silent reservoir of infected birds. The high prevalence of PiCV in apparently healthy pigeons, as documented in Iran (86% overall detection) [3] and Australia [15], means that the virus can circulate undetected within a loft for extended periods. These subclinically infected carriers shed virus intermittently, contaminating the environment and serving as a constant source of infection for newly introduced or immunologically naive birds. The stress of racing, training, molting, or breeding can trigger recrudescence of viral shedding, leading to sudden outbreaks of YPDS even in lofts with no recent history of clinical disease.

The implications for biosecurity are profound. Traditional quarantine protocols, which rely on the absence of clinical signs, are insufficient to prevent the introduction of PiCV into a naive population. The detection of PiCV in environmental samples at international ports [30] underscores the risk of long-distance transport via contaminated equipment or birds. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) recognize the importance of circovirus infections in avian species, and the principles of biosecurity they advocate, including strict isolation of new arrivals, dedicated equipment per loft, and regular monitoring, are directly applicable to PiCV control. However, the high prevalence of the virus and the practical challenges of pigeon husbandry, where birds from multiple sources are routinely mixed for racing and breeding, make eradication an unrealistic goal. Instead, management strategies must focus on reducing viral load within the loft, minimizing stress, and enhancing flock immunity through vaccination, which remains an active area of research [8-10, 18].

Clinical Manifestations and Pathological Features of Young Pigeon Disease

Young Pigeon Disease (YPD), frequently termed Young Pigeon Disease Syndrome (YPDS), represents a complex, multifactorial clinical entity that has been recognized in domestic pigeons (Columba livia domestica) for over three decades. The syndrome is characterized by an acute, often seasonally recurring disorder that predominantly affects juvenile pigeons, typically between the ages of 2 and 12 months, with a peak incidence during the post-weaning and early racing periods [4, 6]. The clinical presentation is highly variable, ranging from subclinical infections to severe, rapidly fatal disease, with mortality rates that can exceed 50% in some outbreaks [14]. The core of the syndrome is believed to be rooted in immunosuppression, most frequently triggered by pigeon circovirus (PiCV), which then predisposes the young bird to secondary infections by a wide array of viral, bacterial, and parasitic pathogens [1, 12, 17]. The clinical manifestations are therefore not the product of a single etiological agent but rather a dynamic interplay between a primary immunosuppressive insult and subsequent opportunistic infections, creating a spectrum of disease presentations that can confound diagnosis.

Clinical Manifestations: The Spectrum of Disease

The clinical signs of YPDS are predominantly gastrointestinal and constitutional, reflecting the primary sites of viral replication and the systemic effects of immunosuppression. The most consistently reported and characteristic signs include crop stasis (congested crop), regurgitation/vomiting, anorexia, and profuse, watery diarrhea [1, 3, 4, 14, 19, 33]. The crop stasis is a particularly notable feature; the crop becomes distended with fluid and ingesta that fails to empty, leading to a palpable, fluctuant swelling at the thoracic inlet. This is often accompanied by the regurgitation of sour-smelling fluid, which can lead to aspiration pneumonia in severe cases. The diarrhea is typically green, mucoid, and watery, rapidly leading to dehydration, electrolyte imbalance, and significant weight loss [3, 4, 19]. Affected birds present as lethargic, depressed, and anorexic, often sitting with ruffled feathers and closed eyes, demonstrating a profound lack of interest in their environment [3, 4]. In racing pigeons, a precipitous drop in performance is an early and critical indicator, with birds failing to complete training flights or returning home exhausted and in poor condition [25].

The severity and specific constellation of clinical signs are heavily influenced by the presence and nature of co-infections. In cases of PiCV and pigeon aviadenovirus A (PiAdV-A) co-infection, the clinical course is often more severe and rapidly progressive. Sahindokuyucu et al. [1, 2] documented natural co-infections in Turkish pigeon flocks where birds exhibited the full spectrum of YPDS signs, crop vomiting, watery diarrhea, anorexia, culminating in sudden death. This exacerbation is likely due to the combined cytopathic effects of adenovirus on hepatocytes and enterocytes, superimposed on the immunosuppressive backdrop created by PiCV. Similarly, the emergence of pigeon rotavirus A (RVA) genotype G18P[15] as a primary causative agent of the classical YPD presentation has been experimentally confirmed. Rubbenstroth et al. [14] fulfilled Henle-Koch’s postulates by demonstrating that peroral inoculation of healthy juvenile pigeons with RVA G18P[15] isolates induced an acute, self-limiting disease characterized by regurgitation, diarrhea, congested crops, anorexia, and weight loss, mirroring the natural disease. The clinical signs were strain-dependent, with one isolate (DR-7) inducing more pronounced illness than another (DR-5), highlighting the role of viral virulence factors in disease outcome [14]. In field outbreaks following fancy pigeon shows, Schmidt et al. [19] reported that clinical signs appeared 7–14 days post-event, with affected birds showing regurgitation, green slimy diarrhea, anorexia, apathy, and death within 24 hours, underscoring the acute and highly contagious nature of RVA in a naïve, stressed population.

Beyond the classic gastrointestinal signs, respiratory and neurological manifestations can occur, particularly when specific secondary pathogens are involved. Columbid alphaherpesvirus 1 (CoHV-1) is a common co-pathogen that can induce suppurative stomatitis, pharyngitis, and rhinitis, often presenting as the "one-eyed cold" or ornithosis complex, with swollen periorbital sinuses and nasal discharge [15, 25, 28]. In severe cases, CoHV-1 can cause encephalitis and fatal systemic disease, especially in PiCV-immunosuppressed birds [15]. Pigeon paramyxovirus type 1 (PPMV-1), a variant of Newcastle disease virus, is another critical pathogen that can cause severe neurological signs, including torticollis, ataxia, and paralysis, along with respiratory distress and high mortality, particularly in young, unvaccinated pigeons [34, 35]. The presence of Chlamydia psittaci, a zoonotic pathogen of significant public health concern (classified as a Category B bioterrorism agent by the CDC and notifiable to the World Organisation for Animal Health, WOAH), can further complicate the clinical picture. In PiCV-infected birds, concurrent chlamydiosis can lead to a lethal outbreak of systemic disease, with affected birds showing severe respiratory distress, conjunctivitis, and sudden death, as documented in a zoo outbreak by Chen et al. [17]. The immunosuppression induced by PiCV is believed to augment the replication and pathogenicity of C. psittaci, leading to more severe clinical outcomes [17, 23].

Pathological Features: The Hallmarks of Immunosuppression and Tissue Damage

The pathological lesions observed in YPDS are a direct reflection of the clinical signs and the underlying viral pathogenesis. The most consistent and diagnostically significant findings are centered on the lymphoid organs, particularly the bursa of Fabricius, which is the primary target of PiCV. Grossly, the bursa in PiCV-infected birds is often atrophied and smaller than expected for the bird's age [12, 15]. Histologically, this atrophy is due to severe, widespread lymphocyte apoptosis and depletion in the bursal follicles [12, 13, 15]. This is the morphological correlate of PiCV-induced immunosuppression. Characteristic botryoid (grape-like) intracytoplasmic inclusion bodies are frequently observed within histiocytes and bursal epithelial cells, and these are pathognomonic for circovirus infection [15, 17]. The presence of these inclusions confirms active viral replication and is a key diagnostic feature on histopathology. The spleen and other lymphoid tissues (e.g., cecal tonsils) may also show lymphoid depletion and the presence of similar inclusion bodies [15]. Dziewulska et al. [13] demonstrated in an experimental One Loft Race (OLR) model that subclinical PiCV infection led to a 40% increase in apoptotic splenic IgM+ B cells compared to controls, confirming that even mild infections cause significant lymphoid damage.

Hepatic lesions are another prominent feature, particularly in cases involving adenovirus or rotavirus co-infection. Grossly, the liver may be enlarged, pale, and friable, with a mottled appearance [24]. Histopathological examination frequently reveals degenerated hepatocytes with basophilic intranuclear viral inclusion bodies, which are characteristic of adenovirus infection [1, 2]. These inclusions are large, amphophilic to basophilic, and fill the nucleus, often pushing the chromatin to the periphery. In RVA infections, the liver shows hyperemia, necrosis, and mononuclear cell infiltrates, indicative of an acute viral hepatitis [14, 24]. Adamczyk et al. [24] described these changes in Polish racing pigeons, noting that the histopathological picture of RVA infection closely resembled that seen in other species with rotaviral hepatitis.

Gastrointestinal tract pathology is consistent with the clinical signs of diarrhea and vomiting. The intestines, particularly the small intestine and ceca, are often distended with fluid and gas. Histologically, there is enteritis characterized by villous atrophy, fusion, and blunting, with necrosis of enterocytes at the tips of the villi [14]. This loss of absorptive surface area explains the malabsorptive diarrhea and weight loss. In adenovirus infections, intranuclear inclusion bodies can be found in enterocytes. The crop may show congestion and edema of the mucosa, correlating with the clinical finding of crop stasis.

Lesions associated with secondary infections can be superimposed on these primary changes. In CoHV-1 co-infections, eosinophilic intranuclear inclusion bodies (Cowdry type A) are found in epithelial cells of the oral mucosa, pharynx, and cloaca, associated with suppurative inflammation and necrosis [15]. Nath et al. [15] reported that in a natural outbreak of PiCV and CoHV-1, lesions included severe suppurative stomatitis, pharyngitis, cloacitis, meningitis, and tympanitis, with high viral loads of both pathogens in affected tissues. In chlamydiosis co-infections, histopathology reveals variable numbers of intracytoplasmic basophilic microorganisms (elementary bodies) within macrophages, hepatocytes, and renal epithelium, alongside the PiCV-associated botryoid inclusions in the bursa [17]. The presence of avian poxvirus can be identified by the presence of large, eosinophilic intracytoplasmic inclusion bodies (Bollinger bodies) in epithelial cells of the skin and oral mucosa, leading to proliferative, nodular lesions [36].

The Role of Viral Load and Co-infection in Pathogenesis

The severity of pathological lesions and clinical signs is directly correlated with viral load. Nath et al. [15] demonstrated that in pigeons naturally co-infected with PiCV and CoHV-1, viral copy numbers for both viruses were significantly higher (p < 0.0001) in clinically affected pigeons compared to subclinically infected, qPCR-positive birds. This indicates that high-level viral replication is a prerequisite for the development of severe disease. The One Loft Race (OLR) system has been identified as a potent amplifier of this process. Stenzel et al. [16] showed that housing young pigeons from different lofts together in an OLR setting led to a peak in PiCV viremia and shedding around day 14, coinciding with the emergence of new recombinant PiCV genotypes. This high level of viral replication, combined with the stress of competition and mixing, creates a perfect storm for the development of YPDS. The initial PiCV infection, by destroying B lymphocytes in the bursa, cripples the humoral immune response, making the bird exquisitely susceptible to secondary infections. The subsequent infection with RVA, adenovirus, or CoHV-1 then proceeds unchecked, leading to the severe, often fatal, clinical and pathological picture that defines the syndrome. The detection of beak and feather disease virus (BFDV) in pigeons [3], a circovirus typically associated with psittacines, further underscores the potential for cross-species transmission and the expanding host range of these immunosuppressive viruses, adding another layer of complexity to the pathogenesis of YPDS.

Co-infection with Pigeon Aviadenovirus A and Synergistic Pathogenesis

The clinical reality of Young Pigeon Disease Syndrome (YPDS) is rarely attributable to a solitary pathogen. Instead, the syndrome’s hallmark severity, its high morbidity, rapid progression, and devastating mortality in juvenile pigeons, is increasingly recognized as a product of intricate viral interplay. Among the most consequential and well-documented synergistic partnerships is that between Pigeon circovirus (PiCV) and Pigeon aviadenovirus A (PiAdV-A). This co-infection paradigm represents a critical nexus where an immunosuppressive primary agent (PiCV) creates a permissive environment for a secondary cytolytic pathogen (PiAdV-A) to express its full pathogenic potential, culminating in a clinical syndrome far exceeding the sum of its parts [1, 2]. Understanding the mechanistic, epidemiological, and diagnostic dimensions of this synergy is not merely an academic exercise; it is fundamental to unraveling the multifactorial etiology of YPDS and developing rational control strategies.

Clinical and Pathological Manifestations of Co-infection

The natural co-infection of PiCV and PiAdV-A was first definitively characterized in a breeding pigeon flock in Central Anatolia, Turkey, where it produced a fulminant disease course characterized by crop vomiting, profuse watery diarrhea, profound anorexia, and sudden death [1, 2]. This clinical picture aligns with the most severe presentations of YPDS, yet its distinctiveness lies in the pathological synergy observed at the tissue level. Histopathological examination of affected pigeons revealed degenerated hepatocytes accompanied by basophilic intranuclear viral inclusions, a hallmark of adenoviral replication and cytopathology [1, 2]. The presence of PiAdV-A inclusions within a liver already compromised by PiCV-induced immunosuppression suggests a mechanism where the host's inability to mount an effective antiviral response allows adenoviral replication to proceed unchecked, leading to massive hepatic necrosis.

This hepatotropic synergy is not an isolated observation. In racing pigeons naturally coinfected with PiCV and Columbid alphaherpesvirus 1 (CoHV1), a similar pattern of augmented lesion development and elevated viral loads was documented [15]. Pigeons succumbing to CoHV1 and PiCV coinfection exhibited severe suppurative stomatitis, pharyngitis, cloacitis, meningitis, and tympanitis, with concurrent detection of large numbers of botryoid intracytoplasmic inclusion bodies in the skin, oral mucosa, and bursa of Fabricius, pathognomonic for circoviral infection [15]. Quantitative analysis revealed that viral copy numbers for both CoHV1 and PiCV were significantly higher (p < 0.0001) in clinically affected pigeons than in subclinical qPCR-positive birds, directly correlating viral burden with disease severity [15]. This pattern of heightened pathogen replication in the presence of PiCV establishes a generalizable principle: PiCV-induced immunosuppression creates a permissive niche for diverse secondary viral and bacterial infections.

Mechanistic Basis for Synergistic Pathogenesis

The synergistic relationship between PiCV and PiAdV-A is rooted in the distinct but complementary pathogenic strategies of each virus. PiCV is a master manipulator of the host immune system, primarily targeting lymphoid tissues. The virus induces marked atrophy of the bursa of Fabricius, spleen, and thymus through the induction of lymphocyte apoptosis, particularly affecting B lymphocytes [6, 12, 13]. This immunosuppressive state is the pathogenic cornerstone upon which secondary infections are built. PiCV subclinical infection (PiCV-SI), while often asymptomatic, still precipitates a degree of immune dysregulation detectable at the molecular level, including altered cytokine expression and reduced humoral immune capacity [18]. In the context of PiCV systemic disease (PiCV-SD), this immunosuppression is profound, leaving the pigeon vulnerable to opportunistic pathogens that would otherwise be controlled by an intact immune system [6, 12].

Pigeon aviadenovirus A, in contrast, is a directly cytolytic virus. As a member of the genus Aviadenovirus, PiAdV-A replicates within the nucleus of infected cells, causing cellular necrosis, particularly in hepatocytes and enterocytes [1, 2, 38]. The virus is shed in feces and is transmitted via the fecal-oral route, a transmission pattern it shares with PiCV, facilitating simultaneous exposure and co-infection [1]. In an immunocompetent host, PiAdV-A infection may be self-limiting or subclinical, as evidenced by its detection in healthy pigeons [37, 38]. However, in a pigeon whose immune surveillance is compromised by PiCV, the adenovirus encounters minimal resistance. The host's impaired ability to produce neutralizing antibodies, coupled with reduced cytotoxic T-cell activity, allows PiAdV-A to replicate to high titers, causing extensive hepatic necrosis and enteritis [1, 12]. This explains the rapid clinical deterioration and high mortality observed in co-infected birds, compared to the milder or inapparent courses of single infections.

Epidemiological Context and Detection Challenges

The epidemiological significance of PiCV/PiAdV-A co-infection is underscored by the high prevalence of PiCV in pigeon populations worldwide. Retrospective molecular investigations in Turkey revealed that PiCV genetic material was the most frequently detected pathogen, found in 25% of sampled flocks, while PiAdV-1 and CoHV-1 were each detected in single flocks [32]. This pattern, high PiCV prevalence with sporadic detection of other pathogens, suggests that PiCV acts as an endemic predisposing factor, with clinical disease erupting only when a susceptible population co-acquires a secondary agent. The detection of PiCV and PiAdV-A in cloacal swabs from YPDS-suspect pigeons in India further corroborates the global relevance of this co-infection [7]. However, accurately diagnosing these coinfections in a clinical setting presents significant challenges.

Traditional uniplex PCR assays, while effective, are time-consuming and reagent-intensive when screening for multiple pathogens. The standardization of multiplex PCR (mPCR) assays targeting the PiCV capsid gene and the PiAdV hexon gene represents a significant diagnostic advance, enabling the simultaneous, rapid, and cost-effective detection of both viruses in a single reaction [7]. This method has proven to be highly specific, yielding distinct amplicons without cross-reactivity, and is invaluable for epidemiological surveillance and routine diagnosis in suspected YPDS outbreaks [7]. The clinical utility of this approach is further enhanced by the development of quantitative PCR (qPCR) and droplet digital PCR (ddPCR) methods for PiCV, which can not only detect the virus but also quantify viral load, a critical parameter for differentiating subclinical infection from active disease [16, 20, 38]. The application of these quantitative tools in co-infection scenarios will be essential for establishing the viral load thresholds that trigger clinical disease and for monitoring the efficacy of potential therapeutic interventions.

Broader Implications for YPDS Pathogenesis

The PiCV/PiAdV-A co-infection model is emblematic of a broader pathogenic landscape in YPDS. The synergistic relationship is not limited to adenoviruses; analogous interactions have been documented with Chlamydia psittaci [17, 23], rotavirus A [14, 19], and columbid alphaherpesvirus 1 [15, 28]. In each case, PiCV infection appears to be a common denominator, lowering the threshold for disease expression by other pathogens. The epidemiological correlation between PiCV and C. psittaci infection in Polish pigeon populations, where birds coinfected with both agents were two to three times more common than those infected with C. psittaci alone, provides compelling evidence for this immunosuppressive-driven synergy [23]. Similarly, the detection of PiCV in 15 of 18 fancy pigeons experiencing RVA-associated disease outbreaks following pigeon shows highlights the role of PiCV as a predisposing factor that amplifies the clinical impact of an otherwise acute but self-limiting rotavirus infection [19].

From a regulatory and public health perspective, the immunosuppressive role of PiCV has implications beyond pigeon health. Chlamydia psittaci is a zoonotic pathogen classified as a Category B bioterrorism agent by the United States Centers for Disease Control and Prevention (CDC), and the World Organisation for Animal Health (WOAH) lists it as a notifiable disease due to its potential for avian-to-human transmission. PiCV-mediated immunosuppression, by facilitating higher loads and prolonged shedding of C. psittaci, may inadvertently increase the zoonotic risk for pigeon fanciers and veterinarians [17, 23]. This underscores the need for integrated One Health approaches to disease surveillance in pigeon populations, linking animal health, ecosystem health, and human public health.

In summary, the co-infection of PiCV and PiAdV-A is not a mere coincidence of two viruses sharing a host; it is a pathogenic partnership driven by PiCV’s capacity to dismantle the host’s immune defenses, thereby unlocking the full cytolytic potential of PiAdV-A. The resulting clinical syndrome, severe hepatic necrosis, enteritis, and rapid death, represents a paradigm of synergistic pathogenesis that is central to understanding YPDS. The high global prevalence of PiCV, combined with the sporadic emergence of PiAdV-A and other secondary pathogens, suggests that YPDS is not a single disease entity but a final common pathway triggered by diverse infectious triggers in an immunosuppressed host. Continued molecular and pathological investigation of these interactions, facilitated by advanced multiplex and quantitative diagnostic tools, is essential for developing effective vaccines and management strategies that target the root cause, PiCV-induced immunosuppression, rather than its myriad downstream consequences.

Diagnostic Approaches: Molecular Detection, Virus Isolation, and Histopathology

The diagnosis of pigeon circovirus (PiCV) infection and its association with young pigeon disease syndrome (YPDS) presents a multifaceted challenge that demands a comprehensive, integrated diagnostic strategy. The inherent complexities of PiCV, including its profound genetic diversity, its propensity for recombination, its predilection for lymphoid tissues, and its near-universal inability to be propagated in conventional cell culture systems, have necessitated the development and refinement of a diverse arsenal of diagnostic tools. These range from highly sensitive nucleic acid detection methods to classical virological isolation techniques and detailed histopathological examination. No single modality is sufficient for a definitive diagnosis; rather, the most robust conclusions are drawn from a synthesis of molecular, virological, and pathological findings, often interpreted in the context of clinical presentation and the detection of co-infecting pathogens, which are a hallmark of YPDS.

Molecular Detection: The Cornerstone of PiCV Diagnosis

The detection of PiCV nucleic acid has become the primary and most reliable diagnostic approach, owing to the virus's high genetic diversity and the current absence of a robust, universally applicable cell culture system for primary isolation. The polymerase chain reaction (PCR) in its various forms has been extensively validated and is considered the gold standard for confirming PiCV infection.

Conventional and Nested PCR

Initial molecular characterization of PiCV relied heavily on conventional PCR assays. A widely adopted strategy targets the replication-associated protein (rep) gene, as this region is relatively conserved across diverse PiCV genotypes. For instance, a nested broad-spectrum PCR utilizing primers targeting a 350-bp fragment of the rep gene was instrumental in demonstrating a PiCV prevalence of 86% in a cohort of pigeons from Iran, highlighting the virus's endemic nature [3]. However, the remarkable genetic variability of PiCV, driven by frequent point mutations and recombination [12], poses a significant risk of false-negative results with single-target conventional PCR. The emergence of recombination events can occur rapidly, particularly under conditions of high-density housing such as the One Loft Race (OLR) system, where up to 25 distinct recombination events were detected in a single experimental cohort over six weeks [16]. This underscores the need for assays that target conserved genomic regions or employ multiplexing strategies.

Quantitative Real-Time PCR (qPCR)

The advent of quantitative real-time PCR (qPCR) represents a significant advancement, offering not only higher sensitivity and specificity but also the critical ability to quantify viral load. This quantification is essential for differentiating between active, clinically relevant infection and subclinical, low-level viral carriage. A robust TaqMan probe-based qPCR assay targeting the rep gene has been developed, demonstrating a limit of detection as low as two plasmid copies, with 100% specificity and sensitivity against a panel of known positive and negative samples, and importantly, no cross-reactivity with other circoviruses such as beak and feather disease virus (BFDV) or canine circovirus [20]. The use of droplet digital PCR (ddPCR) has further refined this approach, providing absolute quantification without the need for standard curves. This technique was pivotal in a study tracking PiCV viremia in young pigeons under OLR conditions, revealing that the peak of viremia occurred around day 14 post-mixing, followed by a sharp decline as the adaptive immune response developed [13]. This temporal data is invaluable for understanding the kinetics of infection and transmission.

Quantitative PCR has also been adapted for the detection of other viral agents implicated in YPDS, facilitating a multi-pathogen approach. For example, specific qPCR assays have been developed for pigeon rotavirus A (RVA) genotype G18P[15], which is now recognised as a primary causative agent of the acute enteric form of YPDS [14, 33]. The ability to detect and quantify both PiCV and RVA from the same clinical specimen is crucial, as co-infections are the rule rather than the exception in cases of severe YPDS. The cycle quantification (Cq) values obtained from qPCR can be directly correlated with clinical outcome; Cq values below 20 in RVA testing have been associated with overt clinical disease (vomiting, diarrhea, stowed crop), whereas values between 20 and 30 often correlate with subclinical infections that still contribute to viral shedding and flock-wide transmission [33].

Multiplex PCR and Pan-Genotypic Detection

Given the polymicrobial nature of YPDS, diagnostic strategies have evolved towards multiplex approaches. A standardized multiplex PCR (mPCR) assay has been developed for the simultaneous detection of PiCV and fowl adenovirus (FAdV), targeting the PiCV capsid (cap) gene and the FAdV hexon gene. This assay was optimized to yield distinct, reproducible amplicons without cross-reactivity, providing a rapid and cost-effective tool for routine diagnosis and epidemiological surveillance [7]. The rational design of such assays must account for the high genetic diversity of the targets. A pan-genotypic indirect competitive ELISA (icELISA) was developed using a monoclonal antibody (1G6-4C4) that targets a conserved conformational epitope of the PiCV capsid protein, successfully detecting antibodies against PiCV strains from groups A through E [5]. This serological approach complements molecular detection by revealing past exposure and population-level immunity, though PCR remains the primary tool for detecting active infection.

Virus Isolation: The Persistent Challenge

Despite decades of research, the isolation of PiCV in conventional cell culture remains a formidable and, for many isolates, insurmountable challenge. This inability to propagate the virus in vitro has been the single greatest impediment to understanding its biology, developing a conventional inactivated vaccine, and conducting controlled experimental infections [8, 9, 12]. The virus's extreme host cell tropism for actively dividing lymphoid cells and its requirement for specific factors present only in the pigeon bursa of Fabricius are likely contributors to this difficulty.

Primary Cell Cultures and Embryonated Eggs

The few reported successes in PiCV isolation have been achieved using complex primary cell culture systems. In a study investigating a co-infection with pigeon aviadenovirus A (PiAdV-A) and PiCV in Turkish pigeons, both viruses were successfully isolated using primary chicken embryo kidney cell cultures (CEKC) and specific pathogen-free (SPF) embryonated chicken eggs [1, 2]. The pooled internal organs from clinically affected pigeons served as the inoculum. However, this approach is technically demanding, resource-intensive, and far from reliable for routine diagnostic use. The presence of the more readily culturable PiAdV-A in the same inoculum in this particular case may have facilitated the isolation, suggesting that PiCV isolation might be more successful in the presence of a helper virus or under specific co-culture conditions. Other attempts have reported limited success using the yolk sac route of inoculation in embryonated pigeon eggs, but consistent propagation has not been achieved on a laboratory scale.

Virus-Like Particles (VLPs) as a Surrogate for Isolation

In lieu of a traditional culture system, the expression of the recombinant capsid protein (rCP) and its self-assembly into virus-like particles (VLPs) has become a critical tool for immunological studies and vaccine development. The PiCV cap gene has been successfully expressed in various systems, including E. coli [11], baculovirus [9], and mammalian HEK-293 cells [8]. These approaches bypass the need for live virus propagation. For example, the PiCV rCap protein expressed in E. coli with a GST tag after codon optimization yielded a soluble protein with good antigenic activity, reaching yields of up to 394 mg/L, which is scalable for diagnostic kit production [11]. The baculovirus-expressed Cap protein self-assembles into non-infectious VLPs with a spherical morphology (15-18 nm), which are structurally and antigenically similar to native virions [9]. While not a replacement for infectious virus isolation, VLP technology provides a critical platform for studying the structure and immunogenicity of the virus.

Histopathology: Revealing the Footprint of Immunosuppression

Histopathological examination remains an indispensable component of the diagnostic workup for YPDS, particularly for understanding the pathophysiological mechanisms of the disease. The hallmark lesions of PiCV infection are centered on the lymphoid organs, reflecting the virus's primary tropism for lymphoblasts and resulting in profound immunosuppression.

Lesions of the Lymphoid Tissues

The bursa of Fabricius is the primary target organ for PiCV. In cases of co-infection with columbid alphaherpesvirus 1 (CoHV1) in Australian racing pigeons, histopathological examination revealed the pathognomonic finding for circovirus infection: numerous, large, botryoid (grape-like) intracytoplasmic inclusion bodies within macrophages and histiocytes of the bursa [15]. These inclusion bodies are composed of tightly packed, non-enveloped icosahedral virions, as confirmed by transmission electron microscopy [17]. The presence of these inclusions is often accompanied by severe lymphoid depletion, follicular atrophy, and necrosis of bursal lymphocytes. This destruction of the bursa, the primary site of B-cell maturation, leads to a profound and long-lasting humoral immunosuppression that predisposes the bird to a wide range of secondary infections [12, 15, 17]. Similar inclusion bodies and cellular degeneration can be observed in the spleen, a secondary lymphoid organ, where they are often associated with a loss of peri-arteriolar lymphoid sheaths and generalised lymphoid depletion [13, 15].

Lesions Associated with Co-Infections

In addition to the primary lymphoid lesions, histopathology frequently reveals the pathology of the co-infecting agent, which is the proximate cause of the clinical signs in YPDS. For instance, in the same Australian co-infection case, the liver and oropharynx exhibited findings consistent with herpesviral infection, including multifocal necrosis and the presence of eosinophilic intranuclear inclusion bodies (Cowdry type A) in hepatocytes and epithelial cells [15]. In cases where PiCV co-occurs with Chlamydia psittaci, histopathology may reveal systemic inflammation, with basophilic intracytoplasmic microorganisms (elementary bodies) visible within macrophages, hepatocytes, and renal epithelial cells alongside the botryoid circoviral inclusions in the bursa [17]. Similarly, in cases dominated by RVA, histopathological changes are prominent in the liver (hepatic necrosis) and spleen, with evidence of pancreatic and renal lesions in some cases [24]. The careful examination of tissues such as the liver, spleen, kidney, and intestine is therefore crucial, as the histological lesions often point to the specific secondary pathogen that has exploited the PiCV-induced immunosuppression. Immunohistochemistry (IHC) using specific antibodies against PiCV capsid protein can be employed to confirm the presence of viral antigen within the characteristic inclusion bodies, providing a definitive link between the histological lesion and the virus [15]. The use of IHC is particularly powerful when used in conjunction with PCR, confirming that the detected nucleic acid corresponds to a productive infection within the lesioned tissue.

Prevention, Control Strategies, and Biosecurity Measures for PiCV-Associated YPDS

The management of pigeon circovirus (PiCV)-associated Young Pigeon Disease Syndrome (YPDS) presents a formidable challenge to the global pigeon industry, encompassing both racing and meat production sectors. Unlike many viral diseases of poultry for which well-established prophylactic protocols exist, PiCV infection occupies a uniquely problematic niche due to its extraordinary genetic diversity, its profound immunosuppressive effects, and the structural realities of modern pigeon husbandry that inherently undermine standard biosecurity principles [6, 12]. Consequently, an integrated control framework must address multiple interconnected vulnerabilities: the absence of a traditional vaccine, the impracticality of viral cultivation for autogenous vaccine production, the high prevalence of subclinical carriers, and the facilitating role of PiCV-induced immunosuppression in precipitating devastating secondary or co-infections. This section provides an exhaustive, evidence-based examination of the prevention, control, and biosecurity measures that can be deployed against PiCV-associated YPDS, drawing upon the most recent virological, immunological, and epidemiological insights.

### The Fundamental Challenge: The Absence of a Conventional Vaccine and the Promise of Virus-Like Particles

A primary impediment to PiCV control is the long-standing inability to propagate the virus in standard cell culture systems, a limitation that has precluded the development of conventional inactivated or live-attenuated vaccines [8, 10, 12]. This biological constraint has forced research efforts toward alternative antigen delivery platforms, with the most promising candidate being the recombinant capsid protein (rCap or rCP) that self-assembles into virus-like particles (VLPs). The PiCV capsid protein, encoded by the cap gene, is the sole structural protein and contains the critical neutralizing antibody epitopes, making it the logical target for subunit vaccine development [8, 9, 11].

The immunogenicity of PiCV rCap-VLPs has been validated across multiple expression systems. Huang et al. [8] demonstrated that subcutaneous immunization of pigeons with 100 µg of PiCV rCap-VLPs produced in a mammalian HEK-293 expression system, combined with a water-in-oil-in-water adjuvant, induced robust humoral and cell-mediated immunity. Critically, vaccinated pigeons experimentally infected with PiCV showed no detectable viral titer, establishing proof-of-concept for VLP-based prophylaxis [8]. Parallel work using a baculovirus expression system has further confirmed the ability of PiCV Cap protein to self-assemble into VLPs with spherical morphology (15–18 nm diameter) and induce specific antibody responses in immunized mice [9]. The advantages of VLP technology are manifold: VLPs are non-infectious as they lack viral genetic material, they present repetitive antigenic structures that potently stimulate B-cell responses, and they can be taken up by dendritic cells to induce cross-presentation and CD8+ T-cell activation, which is particularly relevant given the need to counteract PiCV-induced immunosuppression [8, 9].

Beyond VLP platforms, Stenzel et al. [10] provided foundational evidence that PiCV recombinant capsid protein (rCP) produced in Escherichia coli is immunogenic in pigeons, inducing seroconversion from 23 days post-vaccination and significantly upregulating interferon-gamma (IFN-γ) gene expression as early as two days post-vaccination. This humoral and cellular immune activation is encouraging, yet the same research group subsequently identified a critical practical complication: the immune response to rCP vaccination differs markedly between PiCV-uninfected and subclinically infected pigeons. In naturally infected birds, pre-existing PiCV infection masked the potential cellular immune response to vaccination and suppressed humoral immunity, suggesting that the high prevalence of subclinical carriers in the field may blunt vaccine efficacy [18]. This finding has profound implications for vaccination strategy, indicating that blanket immunization of all pigeons, regardless of infection status, may not yield uniform protection. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have increasingly emphasized the importance of understanding baseline infection dynamics in vaccine deployment, a principle that is directly applicable here.

Subsequent optimization of E. coli expression systems has addressed earlier issues of poor protein solubility and yield. By fusing the PiCV capsid with glutathione-S-transferase (GST) or thioredoxin-His tags, and by optimizing rare codon usage, Lai et al. [11] achieved expression levels of 394.27 ± 26.1 mg/L of soluble GST-rCapopt in E. coli BL21(DE3)-pLysS, with 74.5% of the protein in soluble form. This represents a significant advance toward scalable, cost-effective antigen production for both vaccine and diagnostic applications. However, despite these advances, it remains an open question whether immunization against PiCV alone will be sufficient to control YPDS, given the syndrome's complex, multifactorial etiology involving rotavirus A (RVA), adenoviruses, herpesviruses, and bacterial opportunists [12, 14, 15].

### Biosecurity Imperatives in the Context of Racing and One Loft Race Systems

The biological characteristics of PiCV, its high environmental stability, fecal-oral and possibly respiratory transmission, and prolonged shedding from asymptomatic carriers, intersect dangerously with the social and competitive structures of pigeon racing. The One Loft Race (OLR) system, designed to equalize racing conditions by housing pigeons from multiple breeders in a single facility, represents a high-risk epidemiological amplifier for PiCV transmission and evolution [13, 16]. A landmark study by Dziewulska et al. [13] tracked 15 young racing pigeons naturally infected with PiCV from five different lofts over six weeks under OLR mimicking conditions. Viremia peaked on day 14 and subsequently declined, which correlated with the emergence of specific immunity. However, flow cytometry analysis revealed that the percentage of apoptotic splenic IgM+ B cells was approximately 40% higher in the experimental group than in uninfected controls, confirming that even subclinical PiCV infection inflicts immunological damage [13]. Furthermore, Stenzel et al. [16] recovered 388 complete PiCV genomes from this same OLR experiment, identifying 13 distinct genotypes and 25 recombination events, predominantly occurring during the first three weeks when viremia and shedding were at their peak. The OLR environment thus drives PiCV evolution by facilitating co-infection of individual birds with multiple genotypes, enabling recombination that can generate novel, potentially more virulent strains [16].

These findings mandate rigorous biosecurity protocols for any facility housing pigeons from multiple sources. Quarantine of incoming birds for a minimum of 3–4 weeks, with repeated PCR testing of cloacal swabs or feces, is essential to identify and eliminate or isolate shedders before they enter the main population. Real-time quantitative PCR (qPCR) assays, such as the TaqMan-based method targeting the Rep gene developed by Nath et al. [20], offer a limit of detection as low as 2 plasmid copies with 100% sensitivity and specificity, making them ideal for screening purposes. Routine monitoring should also consider the detection of rotavirus A (RVA), as RVA genotype G18P[15] has been confirmed as a primary cause of YPDS-like disease following peroral inoculation [14]. The work of Adamczyk et al. [33] further underscores that during racing season, transport baskets serve as fomites for RVA transmission, with infection rates peaking by the fourth flight of the season. Given that PiCV-induced immunosuppression likely exacerbates the severity of concurrent RVA, adenovirus, or Chlamydia psittaci infections, the principle of all-in-all-out management for young pigeons, combined with thorough disinfection of all transport equipment, is non-negotiable [15, 17, 23, 33]. Disinfection protocols must account for the robust nature of circoviruses; while specific data on PiCV disinfectant susceptibility are limited, porcine circovirus type 2 (PCV2) is known to be resistant to many common disinfectants, suggesting that oxidizing agents (e.g., peroxygen compounds) or high-concentration chlorine-based products should be prioritized for loft and equipment decontamination.

### Diagnostic Strategies for Targeted Control: Serological Surveillance with icELISA

Accurate, high-throughput diagnostic tools are the bedrock of any evidence-based control program. While PCR-based detection of PiCV DNA in feces, cloacal swabs, or tissues confirms active infection or shedding, it cannot differentiate between current infection and previous exposure, nor can it assess the immune status of a population. To address this gap, Wang et al. [5] developed a pan-genotypic indirect competitive enzyme-linked immunosorbent assay (icELISA) using a monoclonal antibody (1G6-4C4) that recognizes a conserved conformational epitope on the capsid protein. This icELISA can detect antibodies against PiCV strains from groups A through E, overcoming the limitations of PCR and prior serological assays that were often genotype-specific. The assay demonstrated no cross-reactivity with antibodies against other common pigeon pathogens, including pigeon paramyxovirus type 1 (PPMV-1), avian influenza H9N2, fowl adenovirus type 4, and rotavirus, and showed 93.10% concordance with a conventional indirect ELISA [5].

The practical value of icELISA lies in its utility for epidemiological surveillance. Seroprevalence data can inform decisions about vaccination timing: for instance, if a loft shows high seropositivity among young pigeons before the racing season, this may indicate natural exposure and potential immunity, whereas a high proportion of seronegative birds would signal a vulnerable population requiring enhanced biosecurity or prophylactic vaccination. The Centers for Disease Control and Prevention (CDC) has long championed the integration of serosurveillance into infectious disease control, and this approach is directly transferable to PiCV management. By complementing PCR detection (which identifies current infection/shedding) with icELISA serology (which identifies past exposure and immune status), veterinarians and breeders can achieve a comprehensive understanding of PiCV dynamics within a loft, enabling targeted interventions rather than blanket, often ineffective, measures [5].

### Immune Modulation as a Therapeutic and Prophylactic Tool: The Role of Interferon-Alpha

Given the barriers to vaccination, alternative prophylactic and therapeutic approaches merit serious consideration. Santos et al. [39] explored the potential of pigeon interferon-alpha (PiIFN-α) as an antiviral agent against PiCV. Recombinant PiIFN-α was expressed, purified, and tested both in vitro against fowl adenovirus type 4 (FAdV-4) in LMH cells and in vivo in pigeons naturally and experimentally infected with PiCV. Remarkably, no detectable PiCV viral titers were found after treatment with PiIFN-α. The antiviral effect correlated with significant upregulation of IFN-γ and Mx1 gene expression in liver and spleen tissues, indicating activation of the JAK-STAT signaling pathway and downstream interferon-stimulated genes (ISGs) [39]. Furthermore, the PiIFN-α protein demonstrated stability across a range of temperatures and pH conditions for at least 4 hours, suggesting a practical shelf-life for field use.

The use of recombinant type I interferon as a prophylactic or metaphylactic agent during high-risk periods, such as immediately before racing events, after exposure to potentially contaminated show environments, or upon introduction of new birds to a loft, could provide a window of antiviral protection while the birds' adaptive immune responses develop. This strategy aligns with the WOAH's recommendations for using biological response modifiers in disease control where traditional vaccines are unavailable. However, practical considerations include the cost of production, the need for repeated administration, and the potential for the induction of anti-interferon neutralizing antibodies with prolonged use. Nonetheless, when integrated with vaccination (which stimulates long-term adaptive immunity) and stringent biosecurity (which reduces challenge dose), interferon therapy could constitute a critical component of a multi-layered control strategy.

### Managing the Co-Infection Nexus: A Holistic Approach to YPDS Control

No discussion of PiCV control can ignore the reality that YPDS is not a simple monoinfection but a syndrome driven by viral synergy. PiCV-induced immunosuppression, characterized by lymphocyte apoptosis and bursal atrophy, creates a permissive environment for a host of secondary pathogens, including pigeon aviadenovirus A (PiAdV-A), columbid alphaherpesvirus 1 (CoHV-1), Chlamydia psittaci, and Escherichia coli [1, 2, 15, 17, 23, 26]. A study by Nath et al. [15] in Australian racing pigeons demonstrated that PiCV and CoHV-1 co-infection resulted in significantly higher viral copy numbers for both viruses in clinically affected birds compared to subclinically infected ones, and that the herpesviral lesions (suppurative stomatitis, pharyngitis, cloacitis, meningitis) were likely exacerbated by concomitant PiCV infection due to impaired T-cell immunity.

Similarly, Sahindokuyucu et al. [1] reported a natural co-infection of PiCV and PiAdV-A in a Turkish breeding flock, with clinical signs of crop vomiting, watery diarrhea, anorexia, and sudden death. Histopathology revealed degenerated hepatocytes with basophilic intranuclear viral inclusions, indicative of severe hepatic damage [1]. These co-infections are not merely additive but synergistic, with PiCV acting as a gateway pathogen. Therefore, effective control of YPDS must include active surveillance for these co-infecting agents using multiplex PCR assays, such as the one standardized by Santhanalakshmi et al. [7], which can simultaneously detect PiCV and fowl adenovirus. Furthermore, the potential for zoonotic transmission from pigeons cannot be ignored. Chlamydia psittaci is a known zoonotic pathogen causing psittacosis in humans, and PiCV co-infection in pigeons has been correlated with a 2- to 3-fold higher risk of C. psittaci shedding compared to PiCV-negative birds [23]. Consequently, the CDC and WOAH have emphasized the need for a One Health approach to ornithosis control, which directly implicates PiCV management as a public health intervention. Breeders and veterinarians should therefore implement personal protective equipment (PPE) protocols, including gloves, masks, and eye protection, when handling sick birds or cleaning contaminated lofts, particularly in areas with high PiCV and C. psittaci prevalence [23, 25, 35].

### Environmental and Nutritional Interventions

Beyond biological interventions, environmental management is a cornerstone of PiCV control. Overcrowding, poor ventilation, high ammonia levels, and inadequate nutrition are all stressors that can precipitate clinical disease in PiCV-infected birds. Immunosuppressive circoviruses are exquisitely sensitive to host stress: elevated corticosteroids can reactivate latent infections or worsen existing ones. Loft design should prioritize maximum ventilation without drafts, easy-to-clean non-porous surfaces, and separation of age groups to reduce the dose of environmental exposure for naive young birds. Nutritional strategies to support immune function, including adequate levels of vitamin E, selenium, beta-glucans, and probiotics, should be considered adjunctive measures, although controlled trials specifically testing these in PiCV-positive pigeons are lacking. The British Veterinary Poultry Association and equivalent national bodies recommend that any nutritional intervention must be evidence-based and not substituted for core biosecurity.

In summary, the prevention and control of PiCV-associated YPDS demands a multi-pronged, scientifically grounded strategy. The deployment of VLP-based or recombinant subunit vaccines, once validated in field trials, will likely provide the most effective long-term solution. Until then, rigorous biosecurity, including quarantine, molecular surveillance using qPCR, serological profiling with icELISA, strategic use of recombinant interferon, and proactive management of co-infections according to WOAH and national veterinary guidelines, represent the most rational and evidence-based approach to mitigating the devastating impact of this pervasive disease.

References

[1] Sahindokuyucu I, Turkmen MB, Sumer T, Elhag AE, Alçığır M, Yazici Z, et al.. First detection and molecular characterisation of a pigeon aviadenovirus A and pigeon circovirus co‐infection associated with Young Pigeon Disease Syndrome (YPDS) in Turkish pigeons (Columba livia domestica). Veterinary Medicine and Science. 2021. DOI: https://doi.org/10.1002/vms3.662

[2] Sahindokuyucu I, Turkmen MB, Anteplioğlu T, Alçiği̇r E, Yazici Z, Barry G, et al.. Young Pigeon Disease Syndrome (YPDS) in Turkish Pigeons (Columba livia domestica) stemming from coinfection with Pigeon aviadenovirus A and Pigeon circovirus: The first isolation and molecular characterization. . 2020. DOI: https://doi.org/10.22541/au.160434016.62202007/v1

[3] Shabani H, Talazadeh F, Kaydani G, Seifi M. Sequencing of pigeon circovirus and the first report of identification of beak and feather disease virus in clinical specimens of domestic pigeons. Veterinary Research Forum. 2024. DOI: https://doi.org/10.30466/vrf.2023.2002023.3879

[4] Meßmer C, Rubbenstroth D, Mohr L, Peus E, Schreiber T, Rautenschlein S. Pigeon Rotavirus A as the cause of systemic infection in juvenile pigeons (young pigeon disease).. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere. 2022. DOI: https://doi.org/10.1055/a-1909-2235

[5] Wang W, Xiao S, Zhang M, Liu J, Tian J, Chang C, et al.. A pan-genotypic indirect competitive ELISA for serological detection of pigeon circovirus antibodies. Frontiers in Microbiology. 2025. DOI: https://doi.org/10.3389/fmicb.2025.1612715

[6] Silva BB, Urzo ML, Encabo JR, Simbulan AM, Lunaria AJD, Sedano S, et al.. Pigeon Circovirus over Three Decades of Research: Bibliometrics, Scoping Review, and Perspectives. Viruses. 2022. DOI: https://doi.org/10.3390/v14071498

[7] Santhanalakshmi P, Priya PM, Mani B, Ambily R, Pramod S, Anoopraj R. Standardisation of a multiplex PCR for detection of circovirus and adenovirus in pigeons. Journal of Veterinary and Animal Sciences. 2025. DOI: https://doi.org/10.51966/jvas.2025.56.4.692-697

[8] Huang H, Silva BB, Tsai S, Tsai C, Tyan Y, Lin T, et al.. Immunogenicity and Protective Activity of Pigeon Circovirus Recombinant Capsid Protein Virus-Like Particles (PiCV rCap-VLPs) in Pigeons (Columba livia) Experimentally Infected with PiCV. Vaccines. 2021. DOI: https://doi.org/10.3390/vaccines9020098

[9] Gai W, Zheng W, Zhao Z, Wong G, Sun P, Yan L, et al.. Assembly of pigeon circovirus-like particles using baculovirus expression system.. Microbial Pathogenesis. 2019. DOI: https://doi.org/10.1016/j.micpath.2019.103905

[10] Stenzel T, Dziewulska D, Tykałowski B, Śmiałek M, Kowalczyk J, Koncicki A. Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons. Viruses. 2018. DOI: https://doi.org/10.3390/v10110596

[11] Lai G, Lin Y, Tsai Y, Lien Y, Lin M, Chen H, et al.. High yield production of pigeon circovirus capsid protein in the E. coli by evaluating the key parameters needed for protein expression. BMC Veterinary Research. 2014. DOI: https://doi.org/10.1186/1746-6148-10-115

[12] Stenzel T, Koncicki A. The epidemiology, molecular characterization and clinical pathology of circovirus infections in pigeons – current knowledge. Veterinary Quarterly. 2017. DOI: https://doi.org/10.1080/01652176.2017.1325972

[13] Dziewulska D, Tykałowski B, Łukaszuk E, Stenzel T. The course of pigeon circovirus infection in young pigeons experimentally kept under conditions mimicking the One Loft Race rearing system. Journal of Veterinary Research. 2025. DOI: https://doi.org/10.2478/jvetres-2025-0009

[14] Rubbenstroth D, Ulrich R, Wylezich C, Rautenschlein S, Beer M, Mohr L. First experimental proof of Rotavirus A (RVA) genotype G18P[17] inducing the clinical presentation of 'young pigeon disease syndrome' (YPDS) in domestic pigeons (Columba livia).. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13485

[15] Nath B, Das S, Tidd N, Das T, Forwood J, Raidal S. Lesions and viral loads in racing pigeons naturally coinfected with pigeon circovirus and columbid alphaherpesvirus 1 in Australia. Journal of Veterinary Diagnostic Investigation. 2023. DOI: https://doi.org/10.1177/10406387231156839

[16] Stenzel T, Dziewulska D, Łukaszuk E, Custer JM, Koch MDD, Kraberger S, et al.. The pigeon circovirus evolution, epidemiology and interaction with the host immune system under One Loft Race rearing conditions. Scientific Reports. 2024. DOI: https://doi.org/10.1038/s41598-024-64587-3

[17] Chen W, Teng C, Shih C, Huang W, Jiang Y, Chang H, et al.. Investigation of Lethal Concurrent Outbreak of Chlamydiosis and Pigeon Circovirus in a Zoo. Animals. 2021. DOI: https://doi.org/10.3390/ani11061654

[18] Stenzel T, Dziewulska D, Śmiałek M, Tykałowski B, Kowalczyk J, Koncicki A. Comparison of the immune response to vaccination with pigeon circovirus recombinant capsid protein (PiCV rCP) in pigeons uninfected and subclinically infected with PiCV. PLoS ONE. 2019. DOI: https://doi.org/10.1371/journal.pone.0219175

[19] Schmidt V, Kümpel M, Cramer K, Sieg M, Harzer M, Rückner A, et al.. Pigeon rotavirus A genotype G18P[17]-associated disease outbreaks after fancy pigeon shows in Germany – a case series. Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere. 2021. DOI: https://doi.org/10.1055/a-1339-0366

[20] Nath B, Das S, Das T, Forwood J, Raidal S. Development and applications of a TaqMan based quantitative real-time PCR for the rapid detection of Pigeon circovirus (PiCV).. Journal of Virological Methods. 2022. DOI: https://doi.org/10.2139/ssrn.4145120

[21] Al-Baroodi S, Al-Attar M. Isolation and identification of Circovirus in pigeon. Iraqi journal of Veterinary Sciences. 2020. DOI: https://doi.org/10.33899/IJVS.2020.126706.1364

[22] Silva BB, Urzo ML, Montecillo AD, Encabo JR, Chuang J, Chuang K. Retrospective detection and whole genome sequencing identify the first local case of Pigeon Rotavirus A infection in Taiwan from 2018. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-87271-6

[23] Stenzel T, Pestka D, Choszcz D. The prevalence and genetic characterization of Chlamydia psittaci from domestic and feral pigeons in Poland and the correlation between infection rate and incidence of pigeon circovirus.. Poultry Science. 2014. DOI: https://doi.org/10.3382/ps.2014-04219

[24] Adamczyk K, Rubbenstroth D, Ledwoń A, Sapierzyński R, Szeleszczuk P. The first confirmed cases of pigeon rotavirus A (RVA) infection in domestic pigeons (Columba livia) in Poland. Journal of Veterinary Research. 2024. DOI: https://doi.org/10.2478/jvetres-2024-0006

[25] Zigo F, Ondrašovičová S, Farkašová Z, Výrostková J, Regecová I, Rehan IF. Correct interpretation of carrier pigeon diseases – Part 1: Ornithosis complex. International Journal of Avian & Wildlife Biology. 2023. DOI: https://doi.org/10.15406/ijawb.2023.07.00185

[26] Zigo F, Ondrašovičov S, Farkašová Z. Correct interpretation of carrier pigeon diseases - Collibacillosis. International Journal of Avian & Wildlife Biology. 2022. DOI: https://doi.org/10.15406/ijawb.2022.06.00180

[27] Oliyar A, Bohomaz AА, Logvinova V, Nikitina M, Lieshchova M. Morphogenesis of endochondral ossification centres of bones in racing pigeon chicks during the early postnatal period of ontogenesis. Theoretical and Applied Veterinary Medicine. 2021. DOI: https://doi.org/10.32819/2021.94028

[28] Abdellatif W, Osman N, Ahmed AI. A BRIEF REVIEW OF THE COLUMBID ALPHAHERPESVIRUS-1 INFECTION WORLDWIDE. Assiut veterinary medical journal. 2025. DOI: https://doi.org/10.21608/avmj.2025.383972.1705

[29] Kosaka A, Huang C, Lu Z, Hsing H, Choonnasard A, Ringo RS, et al.. Divergent Effects of Circoviridae Capsid Proteins on Type I Interferon Signaling. Pathogens. 2025. DOI: https://doi.org/10.3390/pathogens14010068

[30] He X, Zhang R, Dong J, Zhen W, Zhu L, Ren J, et al.. A metagenomic approach for microbial risk assessment and source attribution in high-risk ports of entry environments. Biosafety and Health. 2025. DOI: https://doi.org/10.1016/j.bsheal.2025.07.001

[31] Sarker S, Moylan KG, Ghorashi S, Forwood J, Peters A, Raidal S. Evidence of a deep viral host switch event with beak and feather disease virus infection in rainbow bee-eaters (Merops ornatus). Scientific Reports. 2015. DOI: https://doi.org/10.1038/srep14511

[32] Sahindokuyucu I, Yazici Z, Barry G. A retrospective molecular investigation of selected pigeon viruses between 2018–2021 in Turkey. bioRxiv. 2022. DOI: https://doi.org/10.1371/journal.pone.0268052

[33] Adamczyk K, Ledwoń A, Czopowicz M, Szeleszczuk P. The course of Rotavirus A (RVA) infection in young racing pigeons during the racing season. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-024-04144-2

[34] Zhang Y, Wang W, Li Y, Liu J, Wang W, Bai J, et al.. A pigeon paramyxovirus type 1 isolated from racing pigeon as an inactivated vaccine candidate provides effective protection. Poultry Science. 2022. DOI: https://doi.org/10.1016/j.psj.2022.102097

[35] P BRR, Rajakumari S. Survey on prevalence of common diseases in pigeon (Columba livia domestica) in Tuticorin district, Tamil Nadu, India. International journal of zoology and applied biosciences. 2021. DOI: https://doi.org/10.55126/ijzab.2021.v06.i04.018

[36] Helal AM, Mahana O, Zanaty A, Selim K, Taha ME, Saleh M, et al.. Identification and genetic analysis of the recent Avian pox viruses from infected pigeons and chickens. Beni-Suef University Journal of Basic and Applied Sciences. 2025. DOI: https://doi.org/10.1186/s43088-024-00589-4

[37] Sardo ER, Talazadeh F, Jafari R, Seifi M. Phylogenetic analysis of pigeon adenovirus 1 in clinical specimens of domestic pigeons (Columba livia domestica) in Iran. Veterinary Research Forum. 2023. DOI: https://doi.org/10.30466/vrf.2022.553719.3471

[38] Łukaszuk E, Dziewulska D, Prątnicka A, Custer JM, Kraberger S, Varsani A, et al.. Characterization, phylogeny and prevalence of the coding-complete genomes of aviadenoviruses and siadenovirus in young racing pigeons.. Virology. 2025. DOI: https://doi.org/10.1016/j.virol.2025.110400

[39] Santos HM, Chen C, Tsai C, Hsish YC, Chung FC, Tyan Y, et al.. Influence of pigeon interferon alpha (PiIFN-α) on pigeon circovirus (PiCV) replication and cytokine expression in Columba livia.. Veterinary Microbiology. 2020. DOI: https://doi.org/10.1016/j.vetmic.2020.108591